241
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Changes in Tear Lipid Layer Thickness and Symptoms Following the Use of Artificial Tears with and Without Omega-3 Fatty Acids: A Randomized, Double-Masked, Crossover Study

ORCID Icon, , , &
Pages 2553-2561 | Published online: 20 Dec 2019

References

  • Sheppard AL, Wolffsohn JS. Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmol. 2018;3(1):e000146. doi:10.1136/bmjophth-2018-000146
  • King-Smith PE. The evaporation barrier of the tear film lipid layer. Invest Ophthalmol Vis Sci. 2016;57(3):959. doi:10.1167/iovs.16-19161
  • Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930–1937. doi:10.1167/iovs.10-6997b
  • Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52(4):1938–1978. doi:10.1167/iovs.10-6997c
  • Moshirfar M, Pierson K, Hanamaikai K, Santiago-Caban L, Muthappan V, Passi SF. Artificial tears potpourri: a literature review. Clin Ophthalmol. 2014;8:1419–1433. doi:10.2147/OPTH.S65263
  • Argiles M, Cardona G, Perez-Cabre E, Rodriguez M. Blink rate and incomplete blinks in six different controlled hard-copy and electronic reading conditions. Invest Ophthalmol Vis Sci. 2015;56(11):6679–6685. doi:10.1167/iovs.15-16967
  • Fogt JS, Kowalski MJ, King-Smith PE, et al. Tear lipid layer thickness with eye drops in meibomian gland dysfunction. Clin Ophthalmol. 2016;10:2237–2243.
  • Korb DR, Scaffidi RC, Greiner JV, et al. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci. 2005;82(7):594–601. doi:10.1097/01.opx.0000171818.01353.8c
  • Walter SD, Gronert K, McClellan AL, Levitt RC, Sarantopoulos KD, Galor A. ω-3 tear film lipids correlate with clinical measures of dry eye. Invest Ophthalmol Vis Sci. 2016;57(6):2472–2478.
  • Dry Eye Assessment and Management Study Research Group, Asbell PA, Maguire MG, et al. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378(18):1681–1690.
  • Giannaccare G, Pellegrini M, Sebastiani S, et al. Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials. Cornea. 2019. doi:10.1097/ICO.0000000000001884
  • JS KM F, King-Smith PE, Barr J. Interferometric measurements of the tear lipid layer thickness following instillation of lipid-containing eye drops and nonlipid-containing eye drops. Invest Ophthalmol Vis Sci. 2016;57. doi:10.1167/iovs.16-19420
  • Braun RJ, King-Smith PE, Begley CG, Li L, Gewecke NR. Dynamics and function of the tear film in relation to the blink cycle. Prog Retin Eye Res. 2015;45:132–164. doi:10.1016/j.preteyeres.2014.11.001
  • JS KM F, Fogt N, King-Smith PE, Barr J. Evaluation of lipid layer thickness of the tears over the course of a day. Invest Ophthalmol Vis Sci. 2017;58. doi:10.1167/iovs.16-20610
  • Schaumberg DA, Gulati A, Mathers WD, et al. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007;5(1):50–57. doi:10.1016/S1542-0124(12)70053-8
  • Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease index and the symptom assessment in dry eye. Ophthalmology. 2015;122(7):1498–1503. doi:10.1016/j.ophtha.2015.02.037
  • Ishak B, Thye J, Mohd Ali B, Mohidin N. Blinking characteristics and corneal staining in different soft lens materials. World Acad Sci Eng Technol. 2012;6(12):1662–1665.
  • Korb DR, Blackie CA, Finnemore VM, Douglass T. Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient/evaporative dry eye. Cornea. 2015;34(4):407–412. doi:10.1097/ICO.0000000000000366
  • Korb DR. British Contact Lens Association. The Tear Film: Structure, Function, and Clinical Examination. Oxford: Butterworth-Heinemann; 2002.
  • Portello JK, Rosenfield M, Chu CA. Blink rate, incomplete blinks and computer vision syndrome. Optom Vis Sci. 2013;90(5):482–487. doi:10.1097/OPX.0b013e31828f09a7
  • Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584. doi:10.1056/NEJM199302253280817
  • Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17(4):565–596. doi:10.1016/S1350-9462(98)00004-4
  • Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A. Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2012;53(8):4396–4406. doi:10.1167/iovs.12-9724
  • Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126(2):219–225. doi:10.1001/archophthalmol.2007.61
  • Li Z, Choi JH, Oh HJ, Park SH, Lee JB, Yoon KC. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. Current Eye Research. 2014;39(9):871–878. doi:10.3109/02713683.2014.884595
  • Amalfitano C, Pasolini MP, Nieddu A, et al. The effect of periocular fatty acids and 0.15% hyaluronate eye drops application on keratoconjunctivitis sicca in dogs: an exploratory study. Top Companion Anim M. 2019;35:18–25. doi:10.1053/j.tcam.2019.03.001
  • Downie LE, Gad A, Wong CY, et al. Modulating contact lens discomfort with anti-inflammatory approaches: a randomized controlled trial. Invest Ophthalmol Vis Sci. 2018;59(8):3755–3766. doi:10.1167/iovs.18-24758
  • Hom MM, Berdy GJ, Downie LE, et al. Clinical evaluation of a novel lipid-containing lubricant eye drop with omega-3 oil and trehalose. Invest Ophthalmol Vis Sci. 2017;58(8):2671. doi:10.1167/iovs.16-20610
  • Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003;38(4):343–352. doi:10.1007/s11745-003-1068-y
  • Miljanović B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82(4):887–893. doi:10.1093/ajcn/82.4.887
  • Deinema LA, Vingrys AJ, Wong CY, Jackson DC, Chinnery HR, Downie LE. A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease. Ophthalmology. 2017;124(1):43–52. doi:10.1016/j.ophtha.2016.09.023
  • Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30(3):308–314. doi:10.1097/ICO.0b013e3181f22e03
  • Sheppard JD Jr., Singh R, McClellan AJ, et al. Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: a randomized double-blind clinical trial. Cornea. 2013;32(10):1297–1304. doi:10.1097/ICO.0b013e318299549c
  • Bradley JL, Özer Stillman I, Pivneva I, Guerin A, Evans AM, Dana R. Dry eye disease ranking among common reasons for seeking eye care in a large US claims database. Clin Ophthalmol (Auckland, NZ). 2019;13:225–232. doi:10.2147/OPTH.S188314